These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 11008324)
61. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease. Chronowski GM; Wilder RB; Tucker SL; Ha CS; Sarris AH; Hagemeister FB; Barista I; Hess MA; Cabanillas F; Cox JD Cancer; 2002 Dec; 95(12):2534-8. PubMed ID: 12467067 [TBL] [Abstract][Full Text] [Related]
62. Treatment of patients with advanced or bulky Hodgkin disease with a 12-week doxorubicin, bleomycin, vinblastine, and dacarbazine-like chemotherapy regimen followed by extended-field, full-dose radiotherapy: long-term results of the Groupe Ouest et Est des Leucémies et Autres Maladies de Sang H90-A/B Multicenter Randomized Trial. Djeridane M; Oudard S; Escoffre-Barbe M; Lacotte-Thierry L; Desablens B; Briére J; Dib M; Cassasus P; Ghandour C; Lamy T; Lejeune F; Simon M; Traullé C; Vigier M; Maisonneuve H; Briére J; Colonna P; Andrieu JM Cancer; 2002 Nov; 95(10):2169-79. PubMed ID: 12412171 [TBL] [Abstract][Full Text] [Related]
63. Combined modality therapy for advanced Hodgkin's disease: long-term followup data. Prosnitz LR; Farber LR; Kapp DS; Bertino JR; Nordlund M; Lawrence R Cancer Treat Rep; 1982 Apr; 66(4):871-9. PubMed ID: 6176322 [TBL] [Abstract][Full Text] [Related]
64. [Function of the lungs in patients with Hodgkin's disease after chemotherapy and radiotherapy]. Milanowski A; Kulus M; Matysiak M; Ochocka M Pediatr Pol; 1988 Nov; 63(11):747-52. PubMed ID: 2473435 [No Abstract] [Full Text] [Related]
65. [Treatment of recurrences of Hodgkin's disease in children]. Armata J; Moryl-Bujakowska A Pol Tyg Lek; 1983 Oct 17-24; 38(42-43):1301-4. PubMed ID: 6201835 [No Abstract] [Full Text] [Related]
67. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages? Andrieu JM; Colonna P J Clin Oncol; 1998 Jun; 16(6):2283. PubMed ID: 9626234 [No Abstract] [Full Text] [Related]
68. [Hodgkin's disease and pregnancy. 3 case reports and a review of the literature]. Abboud J; Nasrallah T; Chahine G; Nasnas R J Gynecol Obstet Biol Reprod (Paris); 1993; 22(7):783-6. PubMed ID: 7508468 [TBL] [Abstract][Full Text] [Related]
69. [Hodgkin's disease. Study of 100 cases]. Sans-Sabrafen J; Pedro Olivé C; Buxó Costa J; Pardo Peret P; Rodríguez Ferrera JC; Woessner S; Galofré M; Rodríguez Méndez F Med Clin (Barc); 1987 Feb; 88(5):175-8. PubMed ID: 3561046 [No Abstract] [Full Text] [Related]
70. Hodgkin's disease and the risk of acute leukemia in successfully treated patients. Valagussa P; Bonadonna G Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571 [No Abstract] [Full Text] [Related]
71. Radiation therapy in the treatment of Hodgkin's disease--do you see what I see? Longo DL J Natl Cancer Inst; 2003 Jul; 95(13):928-9. PubMed ID: 12837820 [No Abstract] [Full Text] [Related]
72. Relapse of Hodgkin's disease after 10 years of complete remission: case report. Mwanda OW; Othieno-Abinya N East Afr Med J; 1998 Mar; 75(3):192-4. PubMed ID: 9640822 [TBL] [Abstract][Full Text] [Related]
74. Infradiaphragmatic Hodgkin's disease: long term results of combined modality therapy. Ifrah N; Hunault M; Jais JP; Moreau P; Desablens B; Casassus P; Briere J; Le Maignan C; Andrieu JM Leuk Lymphoma; 1996 Mar; 21(1-2):79-84. PubMed ID: 8907273 [TBL] [Abstract][Full Text] [Related]
75. [Radiotherapy with neoadjuvant chemotherapy]. Baillet F; Housset M; Dessard-Diana B; Jacquillat C; Michel-Langlet P; Alapetite C Ann Med Interne (Paris); 1989; 140(5):349-52. PubMed ID: 2512829 [TBL] [Abstract][Full Text] [Related]
76. [Combination chemotherapy with total or subtotal lymphatic irradiation in the treatment of lymphogranulomatosis, stage IIIA or IIIB (based on five- and ten-year results)]. Kanaev SV; Gershanovich ML; Malinin AP Vopr Onkol; 1997; 43(1):32-8. PubMed ID: 9133084 [TBL] [Abstract][Full Text] [Related]
77. Combined Modality Treatment for Poor Prognosis Stages I and II Hodgkin's Disease. Cosset JM; Fermé C; Noordijk EM; Dubray BM; Thirion P; Henry-Amar M Semin Radiat Oncol; 1996 Jul; 6(3):185-195. PubMed ID: 10717177 [TBL] [Abstract][Full Text] [Related]
78. Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplant. Redei I; Mangan KF; Ming PL; Mullaney MT; Rao PN; Goldberg SL; Klumpp TR Bone Marrow Transplant; 1997 Mar; 19(5):521-3. PubMed ID: 9052924 [TBL] [Abstract][Full Text] [Related]
79. [Tolerance and results of treatment of Hodgkin's disease]. Krahulová M; Pisarcíková M; Adam Z; Vorlícek J; Hejlová N; Mayer J; Spelda S Vnitr Lek; 1995 Apr; 41(4):243-7. PubMed ID: 7762189 [TBL] [Abstract][Full Text] [Related]
80. Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: an update. Horning SJ; Rosenberg SA; Hoppe RT Ann Oncol; 1996; 7 Suppl 4():105-8. PubMed ID: 8836420 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]